ReviewMalaria journal2025
Enhancing malaria elimination in high-transmission settings: the synergy of concurrent vector control and chemotherapy.
Review in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Hit-To-Lead Optimization of a Pyridylpiperazine Class Against Malaria: Pharmacokinetic Profile and In Vivo Efficacy of Optimized Compounds.ChemMedChem · 2026Article
- Malaria Prevention: Progress to Date.Drugs · 2026Review
- Population size and dispersal of Anopheles coluzzii on São Tomé and Príncipe Islands based on mark-release-recapture.Journal of medical entomology · 2026Article
- Application Strategy and Research Progress of Large-Scale Population Drug Intervention in Malaria Control.Tropical medicine and infectious disease · 2026Review
- Malaria in the 21st Century: Global Disease Burden, Epidemiological Insights, and Strategic Control Approaches.Biology · 2026Review
- Progression from uncomplicated to severe malaria among children in settings receiving different combinations of malaria control interventions in sub-Saharan Africa: a systematic review and meta-analysis.Tropical medicine and health · 2026Review
- Malaria Elimination in Suriname, Timor-Leste and Georgia: Strategic Lessons for Sub-Saharan Africa.Journal of tropical medicine · 2026Review
- Artificial intelligence for precision malaria control: transforming surveillance, prediction, and intervention strategies.Frontiers in digital health · 2026Review
- Plasmodium knowlesi and global changes: socio-ecological drivers and challenges.Malaria journal · 2025Review
- Modelling the impact of different intervention packages for malaria control under varying intensities of pyrethroid resistance.Malaria journal · 2025Article
- Integrated vector and parasite management for malaria control in high-endemic areas: pummel and pin strategy to prevent malaria setbacks.Malaria journal · 2025Review
- Rethinking malaria elimination: a perspective on challenges and solutions in Angola.Malaria journal · 2025Review
- Persistent low-density infection in areas at risk of malaria reintroduction in Malaysia.PloS one · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalaria elimination, defined as interrupting local transmission and reducing cases to zero, is a critical public health goal. While a dual parasite-vector approach is essential, the path to elimination is complex and marked by both progress and setbacks. Despite renewed commitment and initiatives like the "High Burden High Impact" approach, challenges persist, particularly in sub-Saharan Africa. These include shifting epidemiological profiles, weak health systems, drug and insecticide resistance, and emerging global issues. Effective elimination, therefore, requires a multi-pronged approach, scaling-up a package of interventions tailored to transmission intensity, including prompt treatment with ACT, IPTp for pregnant women, vector control measures like IRS and LLINs, and robust community engagement. Ultimately, a combination of contextually appropriate strategies, implemented synergistically, will be crucial to breaking the transmission cycle and achieving sustained malaria elimination. This report aims to review the available evidence on the strategies and deployment of current tools targeting vectors and parasites in resource-limited settings, focusing on sub-Saharan Africa. RECENT
findingsCombining malaria interventions can create a synergistic effect, where the combined impact is greater than the sum of individual interventions. For example, simulations show benefits from combining MDA and IRS, vaccines and bed nets, or the RTS,S vaccine with perennial malaria chemotherapy. However, synergistic effects are not always guaranteed; some combinations, like LLINs and IRS, may not provide additional benefit. Conversely, combining IRS and MDA, or SMC with seasonal malaria vaccination, has demonstrated increased protective effects. Therefore, successful elimination efforts depend on country-specific factors including malaria burden, political commitment, and health system capacity. However, significant biological and operational challenges remain, which may necessitate contextually appropriate approaches to achieve malaria elimination.
conclusionSynergistic intervention effects are crucial, but implementation context is paramount. While combining malaria interventions can be highly effective, not all combinations yield equal results. Thus, tailoring strategies to the specific local context and transmission dynamics is essential for maximizing impact. Moreover, successful malaria elimination is heavily reliant robust health systems and understanding the biological and operational challenges. Consequently, adaptable, evidence-based strategies are required to overcome these obstacles and achieve lasting progress toward malaria elimination.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.